Department of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Department of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Biomaterials. 2023 May;296:122065. doi: 10.1016/j.biomaterials.2023.122065. Epub 2023 Feb 20.
In recent years, nanoparticles derived from cellular membranes have been increasingly explored for the prevention and treatment of human disease. With their flexible design and ability to interface effectively with the surrounding environment, these biomimetic nanoparticles can outperform their traditional synthetic counterparts. As their popularity has increased, researchers have developed novel ways to modify the nanoparticle surface to introduce new or enhanced capabilities. Moving beyond naturally occurring materials derived from wild-type cells, genetic manipulation has proven to be a robust and flexible method by which nanoformulations with augmented functionalities can be generated. In this review, an overview of genetic engineering approaches to express novel surface proteins is provided, followed by a discussion on the various biomedical applications of genetically modified cellular nanoparticles.
近年来,源自细胞膜的纳米粒子在人类疾病的预防和治疗方面的应用越来越受到关注。这些仿生纳米粒子具有灵活的设计和与周围环境有效交互的能力,能够超越传统的合成对应物。随着它们的普及,研究人员已经开发出了新颖的方法来修饰纳米粒子表面,以引入新的或增强的功能。超越源于野生型细胞的天然存在的材料,遗传操作已被证明是一种强大而灵活的方法,可以生成具有增强功能的纳米制剂。在这篇综述中,提供了一种表达新型表面蛋白的遗传工程方法概述,接着讨论了遗传修饰的细胞纳米粒子在各种生物医学应用中的情况。
Biomaterials. 2023-5
J Drug Target. 2015
Int J Mol Sci. 2022-2-17
Adv Mater. 2018-3-27
J Control Release. 2015-12-28
Drug Deliv Transl Res. 2023-3
J Control Release. 2022-11
ACS Appl Mater Interfaces. 2018-6-26
J Nanobiotechnology. 2022-12-22
J Nanobiotechnology. 2025-7-8
Front Immunol. 2025-6-10
Acta Biomater. 2025-1-24
MedComm (2020). 2024-9-17
Nanomaterials (Basel). 2024-2-23
J Control Release. 2023-12
Nat Rev Clin Oncol. 2023-1
Nanoscale Horiz. 2022-6-27
Materials (Basel). 2022-4-30
Adv Drug Deliv Rev. 2022-6
Angew Chem Int Ed Engl. 2022-6-13
Front Med (Lausanne). 2022-2-9